Efg Asset Management (North America) Corp. Exact Sciences Corp Transaction History
Efg Asset Management (North America) Corp.
- $580 Million
- Q1 2025
A detailed history of Efg Asset Management (North America) Corp. transactions in Exact Sciences Corp stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 38,385 shares of EXAS stock, worth $2.02 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
38,385
Previous 50,302
23.69%
Holding current value
$2.02 Million
Previous $2.83 Million
41.22%
% of portfolio
0.29%
Previous 0.4%
Shares
12 transactions
Others Institutions Holding EXAS
# of Institutions
645Shares Held
157MCall Options Held
1.74MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$937 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$927 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$657 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$634 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$347 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.3B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...